HLB Pep Co., Ltd. (KOSDAQ: A196300)
Health Care · Biotechnology · KR
₩4,320.00
-17.24% today · -34.8% 1Y
HLB Pep Co., Ltd. (KOSDAQ: A196300) operates in the Biotechnology industry within the Health Care sector. The company is valued at $30.38M.
Over the last twelve months the share price has lost 34.8%, trading between 3.51K and 9.53K.
Tweenvest scores HLB Pep Co., Ltd. across four factors: quality 55/100, value 47/100. Its strongest factor is quality.
A196300 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $30.38M
- Revenue (TTM)
- $3.58M
- P/E
- —
- EPS
- -993.30
- Dividend yield
- —
- Beta (5Y)
- 0.17
- 52-week high
- ₩9,530.00
- 52-week low
- ₩3,510.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.38M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Oncocross Co., Ltd.KOSDAQ: A382150 | $31.31M | ₩3,200.00 | -12.45% |
| Sernova Biotherapeutics IncTSX: SVA | $30.70M | CA$0.12 | 0.00% |
| Raphael Pharmaceutical Inc.OTCPK: RAPH | $30.47M | $1.51 | — |
| Metagenomi Therapeutics, Inc.NasdaqGS: MGX | $30.43M | $0.81 | -1.30% |
| Genenta Science S.p.A.NasdaqCM: GNTA | $30.38M | $0.63 | -0.01% |
| Aligos Therapeutics, Inc.NasdaqCM: ALGS | $30.35M | $4.86 | -8.99% |
| Immunotech Biopharm LtdSEHK: 6978 | $30.29M | HK$0.39 | -4.94% |
| BriaCell Therapeutics Corp.TSX: BCT | $30.01M | CA$4.88 | -13.01% |
Figures last refreshed Oct 18, 2026.